Related News
Home 禄 Business 禄 Manufacturing
Bayer 鈥榝ully cooperating鈥 in inquiry
Chinese authorities investigated a possible case of unfair competition by the local office of Bayer AG which they visited in late August, the German drug maker said yesterday.
The investigation by the State Administration for Industry and Commerce, responsible for market supervision, showed that China is determined to crack down on corruption and other malpractices in its pharmaceutical industry.
In a statement, Bayer said it is “fully cooperating with the authority” but didn’t release more details.
Bayer, which also makes plastics and crop chemicals, reiterated the company doesn’t tolerate violations and takes appropriate action to ensure its Chinese subsidiary’s marketing and sales activities comply with laws and regulations.
“In case of allegations or non-observance of the Bayer Corporate Compliance Policy by employees, Bayer will investigate them thoroughly and take full responsibility for appropriate measures,” its statement said.
China has been investigating corruption and other illegal practices in the pharmaceutical industry as some drug makers were accused of bribing doctors and hospitals to prescribe drugs, driving up prices and costs for patients.
A number of foreign drug makers, including Eli Lilly of the US, France’s Sanofi and Belgian firm UCB have been investigated by Chinese authorities in the ongoing crackdown that began with British firm GlaxoSmithKline.
Chinese police have detained four Chinese executives of GSK over allegations they had set aside up to 3 billion yuan (US$490.2 million) to offer as bribes since 2007. GSK has also said some senior Chinese executives appear to have broken the law.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.